Literature DB >> 23826422

The expression patterns of gremlin 1 and noggin in normal adult and tumor tissues.

Riikka Laurila1, Seppo Parkkila, Jorma Isola, Anne Kallioniemi, Emma-Leena Alarmo.   

Abstract

Gremlin 1 and noggin are inhibitors of bone morphogenetic protein (BMP) signaling. They are vital during early development but their role in adult tissues has remained largely unresolved. The BMP signaling pathway has also been implicated in tumorigenesis, however with emphasis on the role of the ligands and receptors. We performed a concurrent survey of gremlin 1 and noggin protein expression in multiple normal and cancer samples, using immunohistochemistry on tissue microarrays containing 96 samples from 34 different normal organs/tissue sites and 208 samples of 34 different tumor types. In majority of both normal and tumor samples, gremlin 1 and noggin expression was negative or weak. However, normal stomach and skin demonstrated distinct gremlin 1 and noggin expression indicating a role in adult tissues. Likewise, strong expression of both antagonists was detected in Leydig cells of testis. In the tumor panel, the expression patterns were more variable but elevated BMP antagonist expression was detected for the first time in few cases, such as glioblastoma, hepatocellular carcinoma and diffuse B-cell lymphoma for gremlin 1 and renal granular cell tumor and thyroid papillary carcinoma for noggin. Even though gremlin 1 and noggin were not widely expressed in adult tissues, in a subset of organs their expression pattern indicated a potential role in normal tissue homeostasis as well as in malignancies.

Entities:  

Keywords:  Gremlin 1; cancer; immunohistochemistry; noggin; normal tissue

Mesh:

Substances:

Year:  2013        PMID: 23826422      PMCID: PMC3693206     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  36 in total

Review 1.  Bone morphogenetic proteins and their antagonists.

Authors:  Elisabetta Gazzerro; Ernesto Canalis
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

Review 2.  Bone morphogenetic proteins: multifunctional regulators of vertebrate development.

Authors:  B L Hogan
Journal:  Genes Dev       Date:  1996-07-01       Impact factor: 11.361

3.  Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy.

Authors:  Vincent Dolan; Madeline Murphy; Denise Sadlier; David Lappin; Peter Doran; Catherine Godson; Finian Martin; Yvonne O'Meara; Holger Schmid; Anna Henger; Matthias Kretzler; Alejandra Droguett; Sergio Mezzano; Hugh R Brady
Journal:  Am J Kidney Dis       Date:  2005-06       Impact factor: 8.860

4.  Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration.

Authors:  Brian T Feeley; Nancy Q Liu; Augustine H Conduah; Lucie Krenek; Kevin Roth; William C Dougall; Johnny Huard; Steve Dubinett; Jay R Lieberman
Journal:  J Bone Miner Res       Date:  2006-10       Impact factor: 6.741

5.  Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.

Authors:  Brian T Feeley; Lucie Krenek; Nancy Liu; Wellington K Hsu; Seth C Gamradt; Edward M Schwarz; Johnny Huard; Jay R Lieberman
Journal:  Bone       Date:  2005-08-26       Impact factor: 4.398

6.  Skeletal overexpression of gremlin impairs bone formation and causes osteopenia.

Authors:  Elisabetta Gazzerro; Renata C Pereira; Vanda Jorgetti; Sarah Olson; Aris N Economides; Ernesto Canalis
Journal:  Endocrinology       Date:  2004-11-11       Impact factor: 4.736

7.  Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation.

Authors:  Julie B Sneddon; Hanson H Zhen; Kelli Montgomery; Matt van de Rijn; Aaron D Tward; Robert West; Hayes Gladstone; Howard Y Chang; Greg S Morganroth; Anthony E Oro; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-26       Impact factor: 11.205

Review 8.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

Authors:  C H Heldin; K Miyazono; P ten Dijke
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

9.  Bmp4 and Noggin expression during early thymus and parathyroid organogenesis.

Authors:  Seema R Patel; Julie Gordon; Farah Mahbub; C Clare Blackburn; Nancy R Manley
Journal:  Gene Expr Patterns       Date:  2006-03-06       Impact factor: 1.224

10.  The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein.

Authors:  Hong Namkoong; Seung Min Shin; Hyun Kee Kim; Seon-Ah Ha; Goang Won Cho; Soo Young Hur; Tae Eung Kim; Jin Woo Kim
Journal:  BMC Cancer       Date:  2006-03-18       Impact factor: 4.430

View more
  15 in total

1.  BMP pathway suppression is an early event in inflammation-driven colon neoplasmatogenesis of uPA-deficient mice.

Authors:  George S Karagiannis; Hara Afaloniati; Elisavet Karamanavi; Theofilos Poutahidis; Katerina Angelopoulou
Journal:  Tumour Biol       Date:  2015-09-10

2.  Activin/nodal signaling switches the terminal fate of human embryonic stem cell-derived trophoblasts.

Authors:  Prasenjit Sarkar; Shan M Randall; Timothy S Collier; Anthony Nero; Teal A Russell; David C Muddiman; Balaji M Rao
Journal:  J Biol Chem       Date:  2015-02-10       Impact factor: 5.157

Review 3.  The DAN family: modulators of TGF-β signaling and beyond.

Authors:  Kristof Nolan; Thomas B Thompson
Journal:  Protein Sci       Date:  2014-06-02       Impact factor: 6.725

4.  Increased Expression of Gremlin1 Promotes Proliferation and Epithelial Mesenchymal Transition in Gastric Cancer Cells and Correlates With Poor Prognosis of Patients With Gastric Cancer.

Authors:  Zhiwei Sun; Shuo Cai; Chang Liu; Yuxin Cui; Jiafu Ji; Wen G Jiang; Lin Ye
Journal:  Cancer Genomics Proteomics       Date:  2020 Jan-Feb       Impact factor: 4.069

5.  Gremlin 1+ fibroblastic niche maintains dendritic cell homeostasis in lymphoid tissues.

Authors:  Varun N Kapoor; Sören Müller; Shilpa Keerthivasan; Markus Brown; Cecile Chalouni; Elaine E Storm; Alessandra Castiglioni; Ryan Lane; Maximilian Nitschke; Claudia X Dominguez; Jillian L Astarita; Akshay T Krishnamurty; Catherine B Carbone; Yasin Senbabaoglu; Amber W Wang; Xiumin Wu; Viviana Cremasco; Merone Roose-Girma; Lucinda Tam; Jonas Doerr; Mark Z Chen; Wyne P Lee; Zora Modrusan; Yeqing Angela Yang; Richard Bourgon; Wendy Sandoval; Andrey S Shaw; Frederic J de Sauvage; Ira Mellman; Christine Moussion; Shannon J Turley
Journal:  Nat Immunol       Date:  2021-04-26       Impact factor: 25.606

6.  Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist.

Authors:  Elisabetta Grillo; Cosetta Ravelli; Michela Corsini; Kurt Ballmer-Hofer; Luca Zammataro; Pasqua Oreste; Giorgio Zoppetti; Chiara Tobia; Roberto Ronca; Marco Presta; Stefania Mitola
Journal:  Oncotarget       Date:  2016-06-07

7.  Gremlin1 plays a key role in kidney development and renal fibrosis.

Authors:  Rachel H Church; Imran Ali; Mitchel Tate; Deborah Lavin; Arjun Krishnakumar; Helena M Kok; Jose R Hombrebueno; Philip D Dunne; Victoria Bingham; Roel Goldschmeding; Finian Martin; Derek P Brazil
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-18

8.  Human esophageal myofibroblast secretion of bone morphogenetic proteins and GREMLIN1 and paracrine regulation of squamous epithelial growth.

Authors:  Chunying Zhang; Chao Niu; Kevin Yang; Anisa Shaker
Journal:  Sci Rep       Date:  2018-08-17       Impact factor: 4.379

9.  Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant.

Authors:  Ruggero De Maria; Giorgio Stassi; Veronica Veschi; Laura R Mangiapane; Annalisa Nicotra; Simone Di Franco; Emanuela Scavo; Tiziana Apuzzo; Davide S Sardina; Micol Fiori; Antonina Benfante; Maria L Colorito; Gianfranco Cocorullo; Felice Giuliante; Calogero Cipolla; Giuseppe Pistone; Maria Rita Bongiorno; Aroldo Rizzo; Courtney M Tate; Xiaohua Wu; Scott Rowlinson; Louis F Stancato; Matilde Todaro
Journal:  Oncogene       Date:  2019-10-07       Impact factor: 9.867

10.  Expression of gremlin1 in gastric cancer and its clinical significance.

Authors:  Yoichi Yamasaki; Sumiya Ishigami; Takaaki Arigami; Yoshiaki Kita; Yasuto Uchikado; Hiroshi Kurahara; Yuko Kijima; Kosei Maemura; Shoji Natsugoe
Journal:  Med Oncol       Date:  2018-02-02       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.